🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Estee Lauder stock target cut by Deutsche Bank with maintained Hold rating

Published 10/22/2024, 06:38 PM
© Reuters
EL
-

Estee Lauder (NYSE: NYSE:EL) has experienced a revision in its financial outlook as Deutsche Bank adjusted the company's price target, bringing it down to $98 from the previous $105.

Despite this change, the firm has chosen to maintain its Hold rating on the stock.

The adjustment comes with a detailed analysis from the financial institution, citing a longer-than-anticipated recovery period as the primary reason for the revision.

The bank's analyst pointed out that while the full-year fiscal year 2025 (FY25) earnings per share (EPS) estimate of $2.95 remains consistent with the upper end of Estee Lauder's guidance range of $2.75 to $2.95, there has been a reduction in expectations for fiscal year 2026 and beyond. This includes anticipated figures for sales, gross margin, operating profit, and EPS.

In tandem with the lowered financial forecasts, the price target has been adjusted downwards to $98. This new target reflects the updated expectations and the belief that Estee Lauder's recovery may take longer than initially anticipated.

Despite the reduction in the price target, Deutsche Bank has decided to maintain its Hold rating on Estee Lauder's shares. This suggests that the firm advises investors to retain their positions in the stock at the current time without advocating for additional buying or selling.

In other recent news, Estée Lauder has announced significant leadership changes. Mark Loomis, Group President of North America, is set to retire at the end of fiscal year 2025, with Tara Simon and Amber English named as successors.

In the recent developments, Piper Sandler maintained an Overweight rating on Estée Lauder and increased the company's price target to $122.00, reflecting optimism about the company's near-term prospects, particularly considering recent economic stimulus measures in China.

DA Davidson sustained its Buy rating on Estée Lauder shares with a price target of $130.00, despite an earnings downturn in the first half of fiscal year 2024. Evercore ISI maintained its Outperform rating with a $130.00 price target for Estée Lauder, highlighting the company's recent performance in China's online market. The company's Profit Recovery and Growth Plan aims to deliver between $1.1 and $1.4 billion in net profit over fiscal year 2024 levels.

Additionally, Haider Ackermann has been appointed as the new Creative Director for TOM FORD, a part of Estée Lauder's portfolio. Piper Sandler also reiterated a positive outlook on e.l.f. Beauty (NYSE:ELF), maintaining an Overweight rating and a $150.00 price target for the company's stock after findings from its 48th semi-annual Teen Survey.

InvestingPro Insights

The recent adjustment in Estee Lauder's price target by Deutsche Bank aligns with several key insights from InvestingPro. The company's revenue growth has been sluggish, with a 1.9% decline in the last twelve months as of Q4 2024. This supports the analyst's view of a longer recovery period. However, Estee Lauder maintains impressive gross profit margins of 71.67%, which could provide a buffer during this challenging period.

InvestingPro Tips highlight that Estee Lauder "has maintained dividend payments for 29 consecutive years" and "has raised its dividend for 3 consecutive years." These factors may offer some reassurance to investors during the anticipated extended recovery phase. The current dividend yield stands at 2.96%, which could be attractive to income-focused investors.

It's worth noting that Estee Lauder is "trading at a high earnings multiple," with a P/E ratio of 81.5. This high valuation, combined with the stock taking "a big hit over the last six months" (a 38.67% decline), aligns with Deutsche Bank's cautious Hold rating.

For investors seeking a more comprehensive analysis, InvestingPro offers 7 additional tips that could provide further insights into Estee Lauder's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.